Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Pharmaceutical Business Review
Return to: PBR Home
Latest White Papers
Freeze Drying - Large-Scale Production for Biologics
| By IDT Biologika
IDT's new world-class multi-purpose high-speed filling and large-scale freeze-drying plant for human vaccines (liquid and lyophilized) is equipped to handle and respond to the complex quality and safety demands of current and future live vaccines and immunotherapeutic medicines.
White Papers
IDT Biopharmaceutical Contract Manufacturing
| By IDT Biologika
IDT's special expertise and capabilities include: development and aseptic filling services for parenterals in syringes, vials and ampoules; proven expertise in processing of biopharmaceutical and chemical substances; leading competence in freeze drying of narcotics; and integrated bio and pharma manufacturing site with comprehensive quality control services.
White Papers
IDT Human Vaccines Contract Manufacturing
| By IDT Biologika
IDT produces a wide variety of vaccines for clinical testing and is also developing new technologies for many innovative and future orientated human vaccines, for instance against tuberculosis, AIDS and malaria. Over 20 different vaccines for clinical trials in humans have been handled by IDT to date.
White Papers
Vaccines - Creating Value, Protecting Lives
| By IDT Biologika
IDT is a knowledgeable partner and an expert in the field of biologics contract manufacturing. IDT is focused on four business segments: animal health, vaccines, pharmaceuticals and quality control. We are a vital link in the development chain of new vaccines. Our core competency is in the contract production of viral and bacterial vaccines. We offer a comprehensive portfolio of services and solutions, from development up to large-scale production.
White Papers
pAVEway™ Expression System for the Efficient Expression of Therapeutic Proteins
| By Fujifilm Diosynth Biotechnologies
One of the major bottlenecks in the production of biopharmaceuticals is the efficient expression of therapeutic proteins in microbial or mammalian cells. The Escherichia coli pAVEway™ expression system described here has been developed to ensure high product titres and efficient scale up to GMP manufacture, whilst minimising many common issues seen in other expression systems, such as ‘leaky’ expression (expression of recombinant protein in the absence of inducer).
White Papers
The Cost of Counterfeiting
| By Systech International
Counterfeiting is not a new phenomenon - it is a crime that originated in ancient times. In fact, the practice of currency counterfeiting became so widespread in Roman times, that it was considered a threat to economic stability and punishable by death. Fast forward two thousand years and the economic impact of counterfeiting is once again causing significant concern.
White Papers
Highly Active Pharmaceutical Ingredients
| By Sanofi CEPi
A key activity is the manufacturing of highly active pharmaceutical ingredients (HAP) and cytotoxic compounds. This activity stems from Sanofi’s expertise gained through the manufacturing of taxanes (Docetaxel, Taxotere® and Cabazitaxel, Jevtana®) and in the development of other drugs for oncology. CEPiA is glad to present to customers its dedicated equipment and facilities for highly active products manufacturing.
White Papers
LifeTrain
| By European Medicines Research Training Network (EMTRAIN)
The IMI LifeTrain initiative brought together an extensive group of stakeholders who play an important role in developing, maintaining and employing ‘up-to-date competence’ in the biomedical sector in Europe. LifeTrain addresses how CPD can be better coordinated to support biomedical research in Europe and achieve the goals of IMI and the European Research Area.
White Papers
on-course®
| By European Medicines Research Training Network (EMTRAIN)
The most comprehensive biomedical and medicines research and development postgraduate course portal in Europe.
White Papers
EMTRAIN
| By European Medicines Research Training Network (EMTRAIN)
EMTRAIN is establishing a sustainable, pan-European platform for education and training covering the whole lifecycle of medicines research, from basic science through clinical development to pharmacovigilance.
White Papers
See all White Papers